Latest Articles

Publication Date
All News Scientific
Mali Barbi: Groundbreaking ASCO26 Results Revealing Potential Cure in Advanced Endometrial Cancer - Oncodaily

Mali Barbi: Groundbreaking ASCO26 Results Revealing Potential Cure in Advanced Endometrial Cancer Oncodaily

Published: May 24, 2026, 1:05 p.m.
Read Full Article
Why patients with non-specific symptoms get bounced between specialists—and how to stop it - MDLinx

Why patients with non-specific symptoms get bounced between specialists—and how to stop it MDLinx

Published: May 21, 2026, 10:28 p.m.
Read Full Article
As a graduate nurse, Zoe noticed one thing. It sparked her calls for menstrual leave - MSN

As a graduate nurse, Zoe noticed one thing. It sparked her calls for menstrual leave MSN

Published: May 21, 2026, 6:41 a.m.
Read Full Article
‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected - SurvivorNet

‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected SurvivorNet

Published: May 19, 2026, 9:40 p.m.
Read Full Article
Amy Schumer reveals 'botched' procedure following 50-lb weight loss - HELLO! Magazine

Amy Schumer reveals 'botched' procedure following 50-lb weight loss HELLO! Magazine

Published: May 19, 2026, 12:06 a.m.
Read Full Article
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri - GuruFocus

Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri GuruFocus

Published: May 18, 2026, 11:38 p.m.
Read Full Article
Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer - PharmaLive

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer PharmaLive

Published: May 18, 2026, 1:38 p.m.
Read Full Article
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer - Targeted Oncology

Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer Targeted Oncology

Published: May 18, 2026, 1:33 p.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!